In support of translational relevance, recombinant ADAMTS13 has been shown to restore neutrophil and platelet reconstitution, and reduced activity correlates with increased infection risk and mortality in BMT patients (Peyvandi et al., 2006; Matsui et al., 2014). Here, ADAMTS13 is linked to infection.